China NMPA Product Recall - Hip prosthesis

The National Medical Products Administration (NMPA) published an index on May 17, 2017, regarding a voluntary recall initiated by Howmedica Osteonics Corp., with their reporting dated April 20, 2017. The recall concerns specific hip prostheses, model 0580-1-440, batch number G6106543. The distributor, Stryker (Beijing) Medical Devices Co., Ltd., reported that these devices lacked essential deep markings, a defect identified through customer complaints. Operating under the NMPA's regulatory framework for medical devices, Howmedica Osteonics Corp. confirmed that none of the affected products were sold or imported into China. Consequently, Stryker (Beijing) Medical Devices Co., Ltd. reported the issue to the State Food and Drug Administration but took no further action within China due to the absence of sales. The recall primarily impacted regions such as Japan, Canada, India, and the United Kingdom. Chinese provincial food and drug administrations were requested to strengthen oversight of similar products, emphasizing continuous vigilance in medical device safety and quality management.